Medline Industries recalled 163 DEXLOCK Achilles Repair Implant Kits on November 11, 2025, due to a potential hazard. Users reported drill bits fusing to the drill guide, which may prolong surgical procedures. The recall affects kits distributed nationwide in multiple states.
There have been multiple complaints of drill bit fusing to the bushing/sleeve within the drill guide during use. Retrieving a replacement drill bit and drill guide may prolong the surgical procedure.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the DEXLOCK Achilles Repair Implant Kits, model MAKT4520, with lot number Lot 19019 UDI-DI 10193489131703. These kits were distributed across various states including Alabama, Texas, and Florida, and are classified as Class II medical devices.
The recall stems from multiple complaints of drill bits fusing to the bushing or sleeve within the drill guide. This malfunction poses a risk of prolonged surgical procedures, potentially affecting patient outcomes.
There have been no reported injuries or deaths associated with this recall. However, the high hazard level indicates a serious risk to patients undergoing procedures using these implants.
Stop using the DEXLOCK Achilles Repair Implant Kits immediately. Patients and healthcare providers should follow the recall instructions from Medline Industries and contact their healthcare provider for further guidance.
For more information, contact Medline Industries, LP. Visit their website or call for detailed instructions regarding the recall.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.